Fundación IVI
13
2
2
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
7.7%
1 terminated/withdrawn out of 13 trials
90.0%
+3.5% vs industry average
15%
2 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Proteomic and Biological Characterisation of Plasma for the Study of Changes Following Ovarian Reactivation Treatment
Role: collaborator
Umbilical Cord Plasma for Treating Endometrial Pathologies (Thin Endometrium / Asherman's Syndrome/ Endometria Atrophy)
Role: lead
Effect of Antioxidant Probiotic Administration on Seminal Quality and Reproductive Outcomes.
Role: lead
Use of PRP in Endometrial Reconstruction
Role: lead
Effect of Vitamin D on the Size of Fibroids in Women With Vitamin D Deficiency
Role: lead
Comparison of ICSI Outcomes in Cycles Using Testicular and Ejaculate Sperm From Couples With High SDF
Role: lead
Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation
Role: lead
Evolution of Maternal and Paternal-fetus Attachment in Egg Donation
Role: lead
The Influence of the Vaginal Microbiome on Clinical Pregnancy in Patients Undergoing a Euploid Embryo Transfer: a Prospective Blinded Multicentre Cohort Study
Role: lead
Recombinant LH Prior to Ovarian Stimulation in Poor Ovarian Responders (PRE-LH)
Role: collaborator
4-step ASCOT in POI Women to Promote Follicular Rescue
Role: lead
Biochemical Pregnancy Loss. A Multicenter Retrospective Study
Role: collaborator
Determining the Genetic Profile in Semen Donors With Pregnancy, Donor Versus no Pregnancy Obtained in TRA
Role: collaborator
All 13 trials loaded